Effect of preoperative FOLFOX chemotherapy on CCL20/CCR6 expression in colorectal liver metastases

doi:10.3748/wjg.v17.i26.3109

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 26

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2548)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

237

HTML

1926

Figures (1-5)

210

Tables (1-2)

175

Sum=2548

Jul 14, 2011 (publication date) through Jul 4, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Jul 14, 2011; 17(26): 3109-3116
Published online Jul 14, 2011. doi: 10.3748/wjg.v17.i26.3109

Full Size Figure Download Figure

Figure 4 CCR6 mRNA expression relative to PMM1 and β2M in CRLM patients with (n = 53) and without (n = 29) FOLFOX chemotherapy before CRLM surgery (A) and itemized according to different time points of FOLFOX treatment before CRLM surgery (no FOLFOX therapy, n = 29; FOLFOX treatment ≤ 1 mo, n = 14; FOLFOX treatment ≤ 1 year, n = 22; FOLFOX treatment > 1 year, n = 17) (B). Q-RT-PCR data are expressed as mean ± SE, ^aP < 0.05.

Citation: Rubie C, Frick VO, Ghadjar P, Wagner M, Justinger C, Graeber S, Sperling J, Kollmar O, Schilling MK. Effect of preoperative FOLFOX chemotherapy on CCL20/CCR6 expression in colorectal liver metastases. World J Gastroenterol 2011; 17(26): 3109-3116
URL: https://www.wjgnet.com/1007-9327/full/v17/i26/3109.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i26.3109